Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 4, 2026
- Accession no.
- 0001804146-26-000001
- Filed
- Mar 4, 2026
- Trade date
- Mar 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $11.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | SSaleDisposed | −835 | $1.43 | −$1,194.05 | 372,631 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −2,125 | $1.43 | −$3,038.75 | 370,506 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −1,861 | $1.43 | −$2,661.23 | 368,645 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −2,911 | $1.43 | −$4,162.73 | 365,734 | Direct | |
| Mar 2, 2026 | Common Stock | AGrant or awardAcquired | +100,000 | $0.00 | $0 | 465,734 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.